- Home
- TNON vs TLPH Comparison
TNON vs TLPH Comparison
Compare TNON & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNON
- TLPH
- Stock Information
- Founded
- TNON 2012
- TLPH 2005
- Country
- TNON United States
- TLPH United States
- Employees
- TNON N/A
- TLPH N/A
- Industry
- TNON Medical Specialities
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- TNON Health Care
- TLPH Health Care
- Exchange
- TNON Nasdaq
- TLPH Nasdaq
- Market Cap
- TNON 11.5M
- TLPH 11.1M
- IPO Year
- TNON 2022
- TLPH 2011
- Fundamental
- Price
- TNON $1.18
- TLPH $1.32
- Analyst Decision
- TNON Strong Buy
- TLPH Strong Buy
- Analyst Count
- TNON 2
- TLPH 1
- Target Price
- TNON $5.50
- TLPH $6.00
- AVG Volume (30 Days)
- TNON 158.8K
- TLPH 545.9K
- Earning Date
- TNON 11-12-2025
- TLPH 11-12-2025
- Dividend Yield
- TNON N/A
- TLPH N/A
- EPS Growth
- TNON N/A
- TLPH N/A
- EPS
- TNON N/A
- TLPH N/A
- Revenue
- TNON $2,947,000.00
- TLPH $27,000.00
- Revenue This Year
- TNON $43.52
- TLPH N/A
- Revenue Next Year
- TNON $82.14
- TLPH $14,533.26
- P/E Ratio
- TNON N/A
- TLPH N/A
- Revenue Growth
- TNON N/A
- TLPH N/A
- 52 Week Low
- TNON $0.85
- TLPH $0.38
- 52 Week High
- TNON $5.85
- TLPH $1.45
- Technical
- Relative Strength Index (RSI)
- TNON 46.33
- TLPH 81.47
- Support Level
- TNON $1.15
- TLPH $0.86
- Resistance Level
- TNON $1.25
- TLPH $1.35
- Average True Range (ATR)
- TNON 0.04
- TLPH 0.09
- MACD
- TNON 0.00
- TLPH 0.02
- Stochastic Oscillator
- TNON 30.43
- TLPH 80.24
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.